Personalized Medicine in Ovarian Cancer: A Perspective From Mexico

Ovarian cancer (OC) represents a serious health problem worldwide. In Mexico, most OC patients are detected at late stages, consequently making OC one of the leading causes of death in women after reaching puberty. Personalized medicine (PM) provides an individualized therapeutic opportunity for tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernandez-Garza, Luis E., Dominguez-Vigil, Irma G., Garza-Martinez, Jose, Valdez-Aparicio, Erick A., Barrera-Barrera, Silvia A., Barrera-Saldana, Hugo A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8297048/
https://www.ncbi.nlm.nih.gov/pubmed/34349852
http://dx.doi.org/10.14740/wjon1383
Descripción
Sumario:Ovarian cancer (OC) represents a serious health problem worldwide. In Mexico, most OC patients are detected at late stages, consequently making OC one of the leading causes of death in women after reaching puberty. Personalized medicine (PM) provides an individualized therapeutic opportunity for treating each patient relying on “omic” tools to match the correct drug with the specific pathogenic genomic signature. PM can help predict the best therapeutic option for each affected woman suffering from OC. In recent years, Mexico has made contributions to the PM of OC; however, it still has a long way to go for its full implementation in the country’s health system.

Ejemplares similares